Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Therapie|January 1, 1991
[Drug flow. Good manufacturing practices, good clinical practices]T Dupin-Spriet, A SprietTherapie|May 1, 1993
[Clinical trials in Alzheimer disease. Comments on the project of FDA's guidelines]A Spriet, T Dupin-SprietThe International Journal of Artificial Organs|January 8, 2005
Evaluation of the direct toxicity of trioctyltrimellitate (TOTM), di(2-ethylhexyl) phthalate (DEHP) and their hydrolysis products on isolated rat hepatocytesK Kambia, T Dine, B Gressier, et al.Journal of Clinical Pharmacy and Therapeutics|January 8, 2009
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusionN K Kambia, M Luyckx, T Dine, et al.Journal of Pharmaceutical and Biomedical Analysis|February 15, 2005
Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containersN K Kambia, T Dine, T Dupin-Spriet, et al.European Journal of Drug Metabolism and Pharmacokinetics|October 7, 2003
Induction of propranolol metabolism in isolated rats hepatocytes treated by di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate (MEHP)K Kambia, T Dine, B Gressier, et al.Internal Medicine Journal|March 14, 2008
Provision of information on regulatory authorities' websitesA Vitry, J Lexchin, L Sasich, et al.La Nouvelle Presse Medicale|June 28, 1978
[Predictive studies in psychopharmacology (author's transl)]P Simon, A SprietTherapie|January 1, 1995
[Pentoxifylline and intermittent claudication: critical analysis of clinical trials]O L Charansonney, A SprietTherapie|July 1, 1996
[Essential elements of quality assurance of clinical trials in hospital environment]A Spriet, P Chaumet-RiffaudPageof 3